Tejeda M, Boix J H, Alvarez F, Balanzá R, Morales M
Intensive Care Unit, Hospital General de Requena, Valencia, Spain.
Chest. 1997 May;111(5):1322-5. doi: 10.1378/chest.111.5.1322.
To assess whether pressure support ventilation (PSV) could be used as an alternative ventilatory mode to assist-control (A/C) ventilation in the treatment of respiratory failure.
A short-term (4-h) prospective study in which the beneficial effect of PSV on respiratory mechanics, gas exchange, arterial oxygenation, cardiovascular hemodynamics, and oxygen consumption was compared with A/C ventilation.
ICU of a community hospital.
Forty-five patients (mean age, 62.8 [11.8] years) with respiratory failure secondary to COPD, restrictive disorders, or neuromuscular disease requiring mechanical ventilatory support in the ICU were selected for study.
The mean duration of mechanical ventilation before the study was 7.16 (8.64) days. Patients were switched to the PSV mode of the mechanical ventilator for a period of 4 h after which conventional A/C ventilation was resumed.
Patients supported with PSV compared with A/C ventilation showed significantly higher tidal volume, minute ventilation, and inspiratory time in association with significantly lower pressure in the airway and I:E ratio. With regard to gas exchange data, an increase in dead space/tidal volume ratio (VD/VT), decrease in PaO2, and statistically but not clinically significant alteration of arterial oxygenation indexes were noted. However, when patients with COPD, restrictive disorders, and neuromuscular disease were compared, significant changes in arterial oxygenation parameters were found only in patients with restrictive disorders. There were significant decreases in heart rate, systolic pulmonary artery pressure, and pulmonary capillary wedge pressure when PSV was applied. Oxygen transport and oxygen consumption were unchanged.
PSV could be a possible alternative to A/C ventilation in patients with respiratory failure. PSV caused an increase in VD/VT in association with a significantly lower pressure in the airway and I:E ratio. Randomized studies are needed to define the long-term benefits of both respiratory modes and the conditions in which PSV may be a valuable alternative to A/C ventilation.
评估压力支持通气(PSV)能否作为辅助控制(A/C)通气的替代通气模式用于治疗呼吸衰竭。
一项短期(4小时)前瞻性研究,将PSV对呼吸力学、气体交换、动脉氧合、心血管血流动力学及氧消耗的有益作用与A/C通气进行比较。
一家社区医院的重症监护病房。
选取45例(平均年龄62.8[11.8]岁)因慢性阻塞性肺疾病(COPD)、限制性疾病或神经肌肉疾病继发呼吸衰竭且在重症监护病房需要机械通气支持的患者进行研究。
研究前机械通气的平均时长为7.16(8.64)天。患者转换至机械通气的PSV模式持续4小时,之后恢复常规A/C通气。
与A/C通气相比,接受PSV支持的患者潮气量、分钟通气量及吸气时间显著更高,同时气道压力及吸呼比显著更低。关于气体交换数据,死腔/潮气量比值(VD/VT)增加,动脉血氧分压(PaO2)降低,且动脉氧合指数有统计学意义但无临床意义的改变。然而,比较COPD、限制性疾病及神经肌肉疾病患者时,仅在限制性疾病患者中发现动脉氧合参数有显著变化。应用PSV时心率、收缩期肺动脉压及肺毛细血管楔压显著降低。氧输送及氧消耗未改变。
对于呼吸衰竭患者,PSV可能是A/C通气的一种替代方式。PSV导致VD/VT增加,同时气道压力及吸呼比显著降低。需要进行随机研究以明确两种通气模式的长期益处以及PSV可作为A/C通气有价值替代方式的条件。